Surrozen, Inc./DE
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · South San Francisco, CA
SRZN chart
What traders are saying about $SRZN
Latest postsSurrozen, Inc./DE news
- Surrozen Announces Closing of Second Tranche of March 2025 Private Placement for $95.1 Million
Yahoo Finance ·
- Top Biotech Stock: Guggenheim Names Surrozen as Best Pick
Yahoo Finance ·
- Surrozen secures FDA clearance for SZN-8141 clinical trial
clinicaltrialsarena.com ·
- Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
Yahoo Finance ·
- Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
Yahoo Finance ·
- Surrozen to Present at Upcoming Healthcare Investor Conferences
Yahoo Finance ·
- Surrozen Reports Second Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- Surrozen Highlights Wnt Retina Pipeline, SZN-8141 IND Timeline at H.C. Wainwright
marketbeat.com ·
- We're Not Very Worried About Surrozen's (NASDAQ:SRZN) Cash Burn Rate
Yahoo Finance ·
- Surrozen to Present at Upcoming Healthcare Investor Conference
Yahoo Finance ·
- Surrozen Reports First Quarter 2026 Financial Results and Provides Business Update
Yahoo Finance ·
- Surrozen Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
Surrozen, Inc./DE key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $3.5M | $10.7M | $0 | – |
| Net income | -$242.0M | -$63.6M | -$43.0M | -$36.0M |
| Diluted EPS | $-32.37 | $-21.67 | $-21.33 | $-15.56 |
| Total assets (year end) | $98.7M | $48.5M | $46.1M | $89.4M |
| Cash and equivalents (year end) | $89.2M | $34.6M | $36.0M | $24.7M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Surrozen, Inc./DE
- Ticker
- SRZN (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- South San Francisco, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1824893
- Former names
- Consonance-HFW Acquisition Corp.
Frequently asked questions
What exchange is Surrozen, Inc./DE listed on?
Surrozen, Inc./DE trades on the Nasdaq under the ticker symbol SRZN.
What industry is Surrozen, Inc./DE in?
Surrozen, Inc./DE is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Surrozen, Inc./DE headquartered?
Surrozen, Inc./DE's business address on file with the SEC is in South San Francisco, CA.
When does Surrozen, Inc./DE's fiscal year end?
Surrozen, Inc./DE's fiscal year ends on December 31.
How much revenue did Surrozen, Inc./DE report?
Surrozen, Inc./DE reported $3.5M in revenue for calendar year 2025, according to its SEC filings.